2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine

C80H140N26O2+6 — CID 157178807

IUPAC2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine
SMILESC[N+]1(CCCCc2ncc(N)cc2N)CCCC1.C[N+]1(CCCCc2ncc(N)cc2N)CCCCC1.C[N+]1(CCCCc2ncc(N)cc2N)CCOCC1.C[N+]1(CCCc2ncc(N)cc2N)CCCC1.C[N+]1(CCNc2ncc(N)cc2N)CCOCC1.C[n+]1ccn(CCCc2ncc(N)cc2N)c1
InChIInChI=1S/C15H27N4.C14H25N4O.C14H25N4.C13H23N4.C12H22N5O.C12H18N5/c1-19(8-4-2-5-9-19)10-6-3-7-15-14(17)11-13(16)12-18-15;1-18(6-8-19-9-7-18)5-3-2-4-14-13(16)10-12(15)11-17-14;1-18(8-4-5-9-18)7-3-2-6-14-13(16)10-12(15)11-17-14;1-17(6-2-3-7-17)8-4-5-13-12(15)9-11(14)10-16-13;1-17(4-6-18-7-5-17)3-2-15-12-11(14)8-10(13)9-16-12;1-16-5-6-17(9-16)4-2-3-12-11(14)7-10(13)8-15-12/h11-12H,2-10,16-17H2,1H3;10-11H,2-9,15-16H2,1H3;10-11H,2-9,15-16H2,1H3;9-10H,2-8,14-15H2,1H3;8-9H,2-7,13-14H2,1H3,(H,15,16);5-9H,2-4,13-14H2,1H3/q6*+1
InChIKeyAOIJHYKFASDXIX-UHFFFAOYSA-N
MW1498.18 g/mol
LogP7.11
Rot. Bonds27

About 2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine

2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine (PubChem CID 157178807) has the molecular formula C80H140N26O2+6 and a molecular weight of 1498.18 g/mol. Its IUPAC name is 2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine.

Molecular Properties

Compound Name2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine
PubChem CID157178807
Molecular FormulaC80H140N26O2+6
Molecular Weight1498.18 g/mol
Exact Mass1497.16
IUPAC Name2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine
SMILESC[N+]1(CCCCc2ncc(N)cc2N)CCCC1.C[N+]1(CCCCc2ncc(N)cc2N)CCCCC1.C[N+]1(CCCCc2ncc(N)cc2N)CCOCC1.C[N+]1(CCCc2ncc(N)cc2N)CCCC1.C[N+]1(CCNc2ncc(N)cc2N)CCOCC1.C[n+]1ccn(CCCc2ncc(N)cc2N)c1
InChIInChI=1S/C15H27N4.C14H25N4O.C14H25N4.C13H23N4.C12H22N5O.C12H18N5/c1-19(8-4-2-5-9-19)10-6-3-7-15-14(17)11-13(16)12-18-15;1-18(6-8-19-9-7-18)5-3-2-4-14-13(16)10-12(15)11-17-14;1-18(8-4-5-9-18)7-3-2-6-14-13(16)10-12(15)11-17-14;1-17(6-2-3-7-17)8-4-5-13-12(15)9-11(14)10-16-13;1-17(4-6-18-7-5-17)3-2-15-12-11(14)8-10(13)9-16-12;1-16-5-6-17(9-16)4-2-3-12-11(14)7-10(13)8-15-12/h11-12H,2-10,16-17H2,1H3;10-11H,2-9,15-16H2,1H3;10-11H,2-9,15-16H2,1H3;9-10H,2-8,14-15H2,1H3;8-9H,2-7,13-14H2,1H3,(H,15,16);5-9H,2-4,13-14H2,1H3/q6*+1
InChIKeyAOIJHYKFASDXIX-UHFFFAOYSA-N
XLogP7.11
TPSA428.88 Ų
H-Bond Donors13
H-Bond Acceptors22
Rotatable Bonds27
Heavy Atoms108
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001498.18
LogP ≤ 57.11
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'}

Analyze 2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine?
The IUPAC name of 2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine (CID 157178807) is 2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine.
What is the SMILES notation for 2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine?
The canonical SMILES for 2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine is C[N+]1(CCCCc2ncc(N)cc2N)CCCC1.C[N+]1(CCCCc2ncc(N)cc2N)CCCCC1.C[N+]1(CCCCc2ncc(N)cc2N)CCOCC1.C[N+]1(CCCc2ncc(N)cc2N)CCCC1.C[N+]1(CCNc2ncc(N)cc2N)CCOCC1.C[n+]1ccn(CCCc2ncc(N)cc2N)c1.
What is the InChIKey of 2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine?
The InChIKey is AOIJHYKFASDXIX-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H27N4.C14H25N4O.C14H25N4.C13H23N4.C12H22N5O.C12H18N5/c1-19(8-4-2-5-9-19)10-6-3-7-15-14(17)11-13(16)12-18-15;1-18(6-8-19-9-7-18)5-3-2-4-14-13(16)10-12(15)11-17-14;1-18(8-4-5-9-18)7-3-2-6-14-13(16)10-12(15)11-17-14;1-17(6-2-3-7-17)8-4-5-13-12(15)9-11(14)10-16-13;1-17(4-6-18-7-5-17)3-2-15-12-11(14)8-10(13)9-16-12;1-16-5-6-17(9-16)4-2-3-12-11(14)7-10(13)8-15-12/h11-12H,2-10,16-17H2,1H3;10-11H,2-9,15-16H2,1H3;10-11H,2-9,15-16H2,1H3;9-10H,2-8,14-15H2,1H3;8-9H,2-7,13-14H2,1H3,(H,15,16);5-9H,2-4,13-14H2,1H3/q6*+1.
What are the key properties of 2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine?
2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine has a molecular weight of 1498.18 g/mol, XLogP of 7.11, 27 rotatable bonds, 13 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-(3-methylimidazol-3-ium-1-yl)propyl]pyridine-3,5-diamine;2-[4-(4-methylmorpholin-4-ium-4-yl)butyl]pyridine-3,5-diamine;2-N-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]pyridine-2,3,5-triamine;2-[4-(1-methylpiperidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[4-(1-methylpyrrolidin-1-ium-1-yl)butyl]pyridine-3,5-diamine;2-[3-(1-methylpyrrolidin-1-ium-1-yl)propyl]pyridine-3,5-diamine is sourced from PubChem (CID 157178807), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).